DRUGOME

WIPO WIPO 2019

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke DRUGOME wurde als Wortmarke am 23.04.2019 bei der Weltorganisation für geistiges Eigentum angemeldet.

Markendetails Letztes Update: 30. November 2022

Markenform Wortmarke
Aktenzeichen 1478465
Registernummer 728943
Länder Australien Europäische Gemeinschaft Großbritannien Israel Indien Japan Südkorea Mexiko Norwegen Singapur China Russland
Basismarke CH Nr. 728943, 24. Oktober 2018
Anmeldedatum 23. April 2019
Ablaufdatum 23. April 2029

Markeninhaber

151 West 42nd Street, 15th Floor
New York NY 10036
US

Markenvertreter

901 New York Avenue, NW Washington DC 20001 US

Waren und Dienstleistungen

09 Calculating machines, data processing equipment, computer equipment; computer software; computer software for providing, analyzing and generating reports; computer software for data processing; electronic apparatus, electronic equipment, software, programs and systems for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images and information; electronic apparatus, electronic equipment, software, programs and systems for the conversion, analysis, processing, storage and transmission of artificial intelligence; computer software for database integration; computer software for creating searchable databases of information and data; software for analysis in the fields of public health, healthcare, pharmaceuticals, biomedicine, pharmaceutical and biomedical research and software for analysis of data from clinical trials as well as data from post-authorization research for the marketing of medicines and/or commercial post-launching of medicines; downloadable computer software featuring computer databases of pharmaceuticals, biomedical research, data from clinical trials and data from post-authorization research for the marketing of medicines and/or commercial post-launching of medicines; downloadable computer search engine software for compiling, obtaining and providing updated scientific, medicinal, pharmaceutical and clinical information, and for obtaining and providing news of general interest
35 Advertising; business management; business administration; secretarial services; business research; business information; market research; provision of market research information; data processing services; analysis of business data; analysis, documentation and professional business consultancy services regarding statistics for pharmaceutical and biomedical research, based on artificial intelligence and machine learning; business analysis and statistical analysis relating to healthcare data, pharmaceuticals, biomedical research and clinical trial data as well as data from post-authorization research for marketing of medicines and/or commercial post-launching of medicines; systematization and compilation of data in computer databases, in particular compilation of information into computer databases for research and analysis in the fields of public health, healthcare, pharmaceuticals, biomedicine, pharmaceutical and biomedical research and development, clinical trial data, data from post-authorization research for marketing of medicines and/or commercial post-launching of medicines; business management analyses, professional business consultations and statistical analyses in the field of public health, healthcare, pharmaceuticals, biomedicine, clinical trials, epidemiological research, pharmacoepidemiology research, post-authorization research for marketing of medicines and/or commercial post-launch of medicines and research evaluating epidemiological results
36 Financial analysis; financial consulting; financial valuations and forecasting; financial analysis, namely, compiling and analyzing statistics and data; financial analysis of investments in pharmaceutical and biomedical research and development and clinical trials and post-authorization research for the marketing of medicines and/or commercial post-launching of medicines; financial evaluation, tracking, analysis, forecasting, consultancy, financial advisory and research services relating to public health, healthcare, pharmaceuticals, biomedicine, pharmaceutical and biomedical research and development and clinical trials as well as post-authorization research for the marketing of medicines and/or commercial post-launching of medicines
42 Scientific and technological services and research and design relating thereto; analysis of technical data by computers; pharmaceutical, biomedical, biological therapeutic research services; research in the field of pharmaceutical and biologic therapeutic products; pharmaceutical and biopharmaceutical research and development; providing scientific research information in the field of pharmaceuticals, biomedicine, clinical trials and post-authorization research for the marketing of medicines and/or commercial post-launching of medicines; cloud computing; providing temporary use of online non-downloadable computer software featuring electronic computer databases of pharmaceuticals, biomedicine, pharmaceutical and biopharmaceutical research and development, medical information, clinical trial data as well as data from post-authorization research for the marketing of medicines and/or commercial post-launching of medicines; providing temporary use of online non-downloadable computer software for research in the field of pharmaceuticals and biopharmaceuticals; providing temporary use of online non-downloadable computer software for compiling, obtaining, controlling, managing and providing updated scientific, pharmaceutical, medical and clinical information, and news information of general interest; providing temporary use of non-downloadable software applications accessible via a web site for data analytics, financial analytics and risk management for use in the fields of pharmaceutical and biomedical research and development, clinical trials, and the provision of medical and healthcare services
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
05. November 2022 2022/48 Gaz GB Ablehnung
01. April 2021 2021/14 Gaz JP RAW: Rule 18ter(2)(ii) GP following a provisional refusal
01. April 2021 2021/13 Gaz MX Ablehnung
02. Februar 2021 2021/5 Gaz KR RAW: Rule 18ter(2)(ii) GP following a provisional refusal
01. Februar 2021 2021/6 Gaz IL RAW: Rule 18ter(2)(ii) GP following a provisional refusal
10. September 2020 2020/37 Gaz JP Ablehnung
30. Juni 2020 2020/33 Gaz SG RAW: Rule 18ter(2)(ii) GP following a provisional refusal
19. Juni 2020 2020/29 Gaz NO Ablehnung
28. Mai 2020 2020/25 Gaz KR Ablehnung
21. Januar 2020 2020/4 Gaz AU Ablehnung
20. Januar 2020 2020/4 Gaz IN Ablehnung
15. Januar 2020 2020/4 Gaz RU Ablehnung
13. Januar 2020 2020/4 Gaz IL Ablehnung
07. Januar 2020 2020/2 Gaz EM Ablehnung
13. September 2019 2019/38 Gaz SG Ablehnung
29. August 2019 2019/35 Gaz CN Ablehnung
23. April 2019 2019/28 Gaz CH Eintragung

ID: 141478465